The U.S.

Once-Daily SAMSCA Increases Serum Sodium Levels Through Increase in Free Water Clearance TOKYO and PRINCETON, N.J., May 21 /PRNewswire/ -- Otsuka Pharmaceutical Co., Ltd. (OPC) and Otsuka Pharmaceutical Development and Commercialization, Inc. (OPDC) announced today that the U.S.

Arginine vasopressin (AVP) receptor antagonist now available in new premixed formulation DEERFIELD, Ill., April 1 /PRNewswire/ -- Astellas Pharma US, Inc.

Astellas Pharma US has announced that the FDA has approved a new premixed formulation of Vaprisol: Vaprisol premixed in 5% dextrose.

DEERFIELD, Ill., Oct. 22 /PRNewswire/ -- Astellas Pharma US, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new premixed formulation of Vaprisol: Vaprisol(R) (conivaptan hydrochloride injection) Premixed in 5% Dextrose.